Stoke Therapeutics
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2014-01-01
- Employees
- 110
- Market Cap
- $730.2M
- Introduction
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
Clinical Trials
6
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
- First Posted Date
- 2025-03-12
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- Stoke Therapeutics, Inc
- Target Recruit Count
- 150
- Registration Number
- NCT06872125
- Locations
- 🇺🇸
Phoenix Children's Hospital, Phoenix, Arizona, United States
🇺🇸Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸Cedars Sinai Medical Center, Los Angeles, California, United States
An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome
- First Posted Date
- 2021-02-05
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Stoke Therapeutics, Inc
- Target Recruit Count
- 60
- Registration Number
- NCT04740476
- Locations
- 🇺🇸
University of California San Francisco Medical Center, San Francisco, California, United States
🇺🇸Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸Children's National Medical Center, Washington, District of Columbia, United States
An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome
- Conditions
- Dravet Syndrome
- Interventions
- First Posted Date
- 2020-06-22
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Stoke Therapeutics, Inc
- Target Recruit Count
- 62
- Registration Number
- NCT04442295
- Locations
- 🇺🇸
UCSF Benioff Children's Hospital, San Francisco, California, United States
🇺🇸Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸Children's National Medical Center, Washington, District of Columbia, United States